JP2001520639A - 種々に修飾されたプロテグリン類 - Google Patents

種々に修飾されたプロテグリン類

Info

Publication number
JP2001520639A
JP2001520639A JP51984797A JP51984797A JP2001520639A JP 2001520639 A JP2001520639 A JP 2001520639A JP 51984797 A JP51984797 A JP 51984797A JP 51984797 A JP51984797 A JP 51984797A JP 2001520639 A JP2001520639 A JP 2001520639A
Authority
JP
Japan
Prior art keywords
amino acid
independently
peptide
hydrophobic
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP51984797A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001520639A5 (https=
Inventor
チャン，コンウェイ，シー．
グー，チー，リャン
チェン，ジー
スタインバーグ，デボラ，エー．
レーラー，ロバート，アイ．
エス．エル． ハーウィグ，シルビア
Original Assignee
イントラバイオティクス ファーマシューティカルズ，インコーポレーテッド．
ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イントラバイオティクス ファーマシューティカルズ，インコーポレーテッド．, ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア filed Critical イントラバイオティクス ファーマシューティカルズ，インコーポレーテッド．
Publication of JP2001520639A publication Critical patent/JP2001520639A/ja
Publication of JP2001520639A5 publication Critical patent/JP2001520639A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dentistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paints Or Removers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP51984797A 1995-11-22 1996-11-22 種々に修飾されたプロテグリン類 Ceased JP2001520639A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US56234695A 1995-11-22 1995-11-22
US562,346 1995-11-22
US64981196A 1996-05-17 1996-05-17
US649,811 1996-05-17
US69092196A 1996-08-01 1996-08-01
US690,921 1996-08-01
US08/752,852 US5994306A (en) 1995-11-22 1996-11-21 Fine-tuned protegrins
US08/752,852 1996-11-21
PCT/US1996/018544 WO1997018826A1 (en) 1995-11-22 1996-11-22 Fine tuned protegrins

Publications (2)

Publication Number Publication Date
JP2001520639A true JP2001520639A (ja) 2001-10-30
JP2001520639A5 JP2001520639A5 (https=) 2004-10-28

Family

ID=27415886

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51984797A Ceased JP2001520639A (ja) 1995-11-22 1996-11-22 種々に修飾されたプロテグリン類

Country Status (12)

Country Link
US (1) US5994306A (https=)
EP (1) EP0862448A4 (https=)
JP (1) JP2001520639A (https=)
KR (1) KR19990071546A (https=)
CN (1) CN1251041A (https=)
AU (1) AU720467B2 (https=)
BR (1) BR9611565A (https=)
CZ (1) CZ159198A3 (https=)
HU (1) HUP0104431A2 (https=)
NO (2) NO982310L (https=)
PL (1) PL336763A1 (https=)
WO (2) WO1997018827A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022510770A (ja) * 2018-10-19 2022-01-28 リップタイド バイオサイエンス インコーポレイテッド 抗菌性ペプチド及びその使用方法
US12564617B2 (en) 2019-04-12 2026-03-03 Riptide Bioscience, Inc. Methods for modulating macrophage activity

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159936A (en) * 1993-07-20 2000-12-12 The Regents Of The University Of California Compositions and methods for treating and preventing microbial and viral infections
US6653442B1 (en) 1993-07-20 2003-11-25 Intrabiotics Pharmaceuticals, Inc. Protegrins
USRE38828E1 (en) * 1995-07-06 2005-10-11 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
US6307016B1 (en) * 1995-07-06 2001-10-23 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
FR2767323B1 (fr) * 1997-08-12 2001-01-05 Synt Em Peptides lineaires derives de peptides antibiotiques, leur preparation et leur utilisation pour vectoriser des substances actives
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
KR100314721B1 (ko) * 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
DE69933785T2 (de) * 1998-03-12 2007-10-04 Georgetown University Peptide enthaltend eine cholesterin-erkennungssequenz und deren verwendungen
US7223727B2 (en) 1998-04-09 2007-05-29 Serono Genetics Institute S.A. GSSP4 polynucleotides and polypeptides and uses thereof
EP0974360A3 (en) * 1998-06-26 2000-03-29 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
CA2332127A1 (en) * 1998-06-26 2000-01-06 N.V. Nutricia Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
DE69903732T2 (de) * 1998-07-02 2003-07-03 Stichting Skeletal Tissue Engineering Group Amsterdam, Amsterdam Knochenzement mit antimikrobiellen peptiden
AU5006499A (en) * 1998-07-23 2000-02-14 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the treatment or prevention of pulmonary infections
US6335318B1 (en) 1999-05-10 2002-01-01 The Regents Of The University Of California Antimicrobial theta defensins and methods of using same
JP2003516150A (ja) 1999-12-08 2003-05-13 ジェンセット 潜在性分泌タンパク質をコードする全長ヒトｃＤＮＡ
CA2391356A1 (en) * 1999-12-21 2001-06-28 Innogenetics N.V. Peptides designed for the diagnosis and treatment of rheumatoid arthritis
BR0001870B1 (pt) * 2000-05-29 2014-02-25 Peptídeo, processo de obtenção de peptídeo, formulação compreendendo peptídeo, método de prevenção de crescimento de parasitas, fungos e bactérias, método para inativar a endotoxina de bactérias gram-negativas
GB0031425D0 (en) * 2000-12-22 2001-02-07 Amoebics Ltd Antibacterial treatments
KR100738362B1 (ko) * 2001-03-19 2007-07-12 재단법인서울대학교산학협력재단 신규한 디아민디티올 유도체 및 그의 방사성 레늄 또는방사성 테크네슘 착체； 그리고, 그의 방사성 레늄 착체와리피오돌을 포함하는 간암 치료용 조성물 및 그의 제조용키트
US20040235745A1 (en) * 2001-06-22 2004-11-25 Deber Charles M Antimicrobial Peptides
US7033991B2 (en) * 2001-07-16 2006-04-25 Board Of Supervisors Of Louisiana State University And Agriculture And Mechanical College Inhibiting furin with polybasic peptides
WO2003062266A2 (en) * 2002-01-22 2003-07-31 Intrabiotics Pharmaceuticals, Inc. Hybrid synthetic method for antimicrobial peptides
CA2482995C (en) 2002-04-22 2013-01-29 Dow Global Technologies Inc. Low-cost production of peptides
US7119070B2 (en) * 2002-04-30 2006-10-10 The Regents Of The University Of California Antimicrobial theta defensins, analogs thereof, and methods of use
AU2003246644A1 (en) * 2002-07-08 2004-01-23 Genova, Ltd. Secreted peptides
US20080255052A1 (en) * 2004-12-23 2008-10-16 The Regents Of The University Of California Immunologic regulation by theta defensins
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
CA2661634C (en) 2006-09-06 2017-03-28 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
CN102088991A (zh) 2008-05-13 2011-06-08 堪萨斯大学 金属提取肽标签和相关方法
TWI394578B (zh) * 2009-01-09 2013-05-01 Academia Sinica 抗菌蛋白之新用途
US20100202983A1 (en) * 2009-02-09 2010-08-12 Jernberg Gary R Selectively targeted antimicrobials for the treatment of periodontal disease
DK2709619T3 (en) 2011-05-16 2018-01-15 Cellceutix Corp RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
WO2014052438A1 (en) 2012-09-25 2014-04-03 Regents Of The University Of Minnesota Methods for making and using antimicrobial peptides
CN103623391B (zh) * 2013-10-10 2014-12-31 中山大学 抗菌肽Protegrin-1在防治猪蓝耳病中的应用
RU2016117275A (ru) 2013-11-01 2017-12-04 Сфериум Биомед С.Л. Тельца включения для трансдермальной доставки терапевтических и косметических средств
CN103936827B (zh) * 2014-04-22 2015-10-14 福州大学 一种韭菜籽抗菌三肽及其制备方法与应用
CN105175509A (zh) * 2015-10-19 2015-12-23 河南科技学院 一种抗菌肽xyz-1及其应用
CN108524911B (zh) * 2018-02-27 2022-03-08 成都山信药业有限公司 Protegrin-1抗菌肽衍生物在制备抗口腔致病菌药物中的用途
WO2020139852A1 (en) 2018-12-28 2020-07-02 General Probiotics, Inc. Combinations of engineered antimicrobial probiotics for treatment of gastrointestinal tract pathogens
WO2021248008A1 (en) 2020-06-05 2021-12-09 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
CN113975373A (zh) * 2021-11-18 2022-01-28 宁波市眼科医院 眼用制剂

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543252A (en) * 1982-01-21 1985-09-24 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US4659692A (en) * 1982-11-19 1987-04-21 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US4705777A (en) * 1985-02-25 1987-11-10 The Regents Of The University Of California Cationic oligopeptides having microbicidal activity
US5126257A (en) * 1986-11-26 1992-06-30 Cornell Research Foundation Antimicrobial proteins, compositions containing same and uses thereof
US5087569A (en) * 1986-11-26 1992-02-11 Cornell Research Foundation, Inc. And The Rockefeller University Antimicrobial proteins, compositions containing same and uses thereof
US5338724A (en) * 1986-11-26 1994-08-16 Cornell Research Foundation, Inc. Antimicrobial proteins, compositions containing same and uses thereof
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5234912A (en) * 1989-02-14 1993-08-10 Incyte Pharmaceuticals, Inc. Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof
US5334584A (en) * 1989-02-14 1994-08-02 Incyte Pharamaceuticals, Inc. Recombinant, non-glycosylated bpi protein and uses thereof
US5171739A (en) * 1989-02-14 1992-12-15 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and preventation thereof using a BPI protein
US5308834A (en) * 1989-02-14 1994-05-03 Incyte Pharmaceuticals, Inc. Treatment of endotoxin-associated shock and prevention thereof using a BPI protein
US5102870A (en) * 1989-04-14 1992-04-07 Schering Ag Treatment and prevention of oral mucositis with growth factors
US5607916A (en) * 1989-07-05 1997-03-04 The Board Of Regents Of The University Of Oklahoma Method and composition for the treatment of septic shock
US5484885A (en) * 1989-07-05 1996-01-16 Emory University Chemotactic, antibiotic and lipopolysaccharide-binding peptide fragments of CAP37
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5432270A (en) * 1990-10-25 1995-07-11 Zasloff; Michael A. DNA encoding tracheal antimicrobial peptides
AU667479B2 (en) * 1991-06-12 1996-03-28 Magainin Pharmaceuticals, Inc. Treating the oral cavity with ion-channel forming peptides
US5488035A (en) * 1991-12-06 1996-01-30 Pioneer Hi-Bred International, Inc. Peptide with inhibitory activity towards plant pathogenic fungi
WO1993024139A1 (en) * 1992-05-26 1993-12-09 The Regents Of The University Of California Antibiotic cryptdin peptides and methods of their use
JPH08504085A (ja) * 1992-07-17 1996-05-07 パノラマ リサーチ，インコーポレイティド リポ多糖体結合及び抗擬血活性をもつ哺乳動物のカチオン性タンパク質
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
WO1994028921A1 (en) * 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5693486A (en) * 1993-07-20 1997-12-02 Intrabiotics DNA sequences encoding protegrins and protegrin analogs and their use in recombinant methods of producing protegrins
US5804558A (en) * 1993-07-20 1998-09-08 University Of California Protegrins
US5464823A (en) * 1993-07-20 1995-11-07 The Regents Of The University Of California Mammalian antibiotic peptides
US5708145A (en) * 1993-07-20 1998-01-13 University Of California Immunglobulins reactive with protegrins
JPH08504837A (ja) * 1993-10-14 1996-05-28 生化学工業株式会社 新規ポリペプチドおよびこれから調製される抗ｈｉｖ剤
US5804553A (en) * 1994-04-05 1998-09-08 University Of California Prophenins - antibiotic peptides
US5589364A (en) * 1994-07-29 1996-12-31 Magainin Pharmaceuticals Inc. Recombinant production of biologically active peptides and proteins
CA2226121A1 (en) * 1995-07-06 1997-01-23 Intrabiotics Pharmaceuticals, Incorporated Parevins and tachytegrins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022510770A (ja) * 2018-10-19 2022-01-28 リップタイド バイオサイエンス インコーポレイテッド 抗菌性ペプチド及びその使用方法
US12564617B2 (en) 2019-04-12 2026-03-03 Riptide Bioscience, Inc. Methods for modulating macrophage activity

Also Published As

Publication number Publication date
HUP0104431A2 (hu) 2002-03-28
US5994306A (en) 1999-11-30
CN1251041A (zh) 2000-04-19
AU720467B2 (en) 2000-06-01
AU7739496A (en) 1997-06-11
NO982311L (no) 1998-07-22
PL336763A1 (en) 2000-07-17
EP0862448A1 (en) 1998-09-09
NO982310D0 (no) 1998-05-20
CZ159198A3 (cs) 1998-10-14
BR9611565A (pt) 1999-12-28
NO982311D0 (no) 1998-05-20
WO1997018827A1 (en) 1997-05-29
KR19990071546A (ko) 1999-09-27
EP0862448A4 (en) 1999-03-31
NO982310L (no) 1998-07-22
WO1997018826A1 (en) 1997-05-29

Similar Documents

Publication Publication Date Title
JP2001520639A (ja) 種々に修飾されたプロテグリン類
AU716277B2 (en) Protegrins
US6025326A (en) Compositions and methods for the prevention and treatment of oral mucositis
CN114269771B (zh) Romo1来源抗微生物肽及其变体
JP2001503020A (ja) 広域抗菌活性を有する環状ペプチド
WO1996037508A9 (en) Protegrins
JPH09503383A (ja) プロテグリン
US6043220A (en) Threonine-containing protegrins
AU2005307160B2 (en) Novel antimicrobial peptides
US20040152638A1 (en) Protegrins
US6653442B1 (en) Protegrins
JPH11509842A (ja) パレビン及びタキテグリン
US5998374A (en) Clavaspirins
WO1998038309A9 (en) Clavaspirins
US6040293A (en) Clavanins
WO1991019512A1 (en) Antimicrobial peptides
AU704851B2 (en) Compositions and methods for the prevention and treatment of oral mucositis
JPWO2008114577A1 (ja) 抗菌性ペプチド
US6010876A (en) Clavanins
CA2238610A1 (en) Fine tuned protegrins
AU714294C (en) Parevins and tachytegrins

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060912

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20070205

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070320